ALTO-100 in Bipolar Disorder with Depression (BD-D)

Recruiting

Phase 2

ALTO-100 in Bipolar Disorder with Depression (BD-D)ALTO-100 in Bipolar Disorder with Depression (BD-D)

Sponsor:

Alto Neuroscience

Code:

NCT06656416

Conditions

Bipolar Disorder I or II with a Major Depressive Episode

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

ALTO-100

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Alto Neuroscience on 2024-10-24.